Nucleoside analogues. Synthesis of 2′,3′-dideoxy and 2′,3′-unsaturated ribofuranonucleosides of 5,6-dichloro-2-mercaptobenzimidazole as potential antiviral agents
- 1 January 1994
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 8,p. 1019-1024
Abstract
Novel benzimidazole nucleoside derivatives structurally related to 5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (DRB) and to tetrahydroimidazobenzodiazepinethione (TIBO) compounds have been synthesized and their antiviral properties examined. The 2′,3′-unsaturated nucleoside was obtained following chemical transformations of the corresponding β-D-ribofuranonucleoside, whereas the 2′,3′-dideoxynucleoside was synthesized by a glycosylation reaction between a suitably protected 2,3-dideoxy-D-glycero-pentofuranose and silylated 5,6-dichloro-2-mercaptobenzimidazole. The prepared compounds were tested for their activity against HIV and against a variety of RNA and DNA viruses, but they did not show significant antiviral activity.Keywords
This publication has 45 references indexed in Scilit:
- Present Status and Future Prospects for HIV TherapiesScience, 1993
- HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptaseMedicinal Research Reviews, 1993
- Antiviral Therapy in Human Immunodeficiency Virus InfectionsDrugs, 1993
- Antiviral Therapy in Human Immunodeficiency Virus InfectionsDrugs, 1993
- Nucleoside Analogs: Similarities and DifferencesClinical Infectious Diseases, 1993
- AIDS-driven nucleoside chemistry.Chemical Reviews, 1992
- HIV Inhibitors Targeted at the Reverse TranscriptaseAIDS Research and Human Retroviruses, 1992
- Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1987
- Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.Proceedings of the National Academy of Sciences, 1986
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.Proceedings of the National Academy of Sciences, 1985